Strategies for tough times
Squeezed between stringent regulations on the home front and sluggish global economic conditions, the Indian pharmaceutical market…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Multisorb Technologies to exhibit solutions for pharmaceutical stability at MEDICA/COMPAMED 2013
To have experienced staff on hand to discuss its solutions for stabilising pharmaceutical, in-vitro diagnostic, medical device,…
Indoco’s sales and EBIDTA margins improve substantially
Posts total revenue growth of 24.8 per cent at Rs 2023 million
Lupin posts robust profits, sees consistent growth
Net sales up 18 per cent; EBITDA up 42 per cent and net profit up 40 per cent
Venus Remedies to launch Elores in Latin America next year
Expects to generate a revenue of $5 million within three years of the launch
Merck India provides solution to overcome counterfeiting
Helps in reducing health hazards and also increasing safety of consumers
Alembic Pharmaceuticals revenues up 20 per cent at Rs 488 crores for quarter ended September 30th,…
PBT up 52 per cent at Rs 80.49 crores
Wockhardt posts second quarter and first half results for the financial year 2014
The consolidated revenue for the quarter ended September 30 was Rs 1197 crore
Unichem Laboratories receives ANDA approval from US FDA
Amlodipine Besylate tablets is indicated for the treatment of hypertension, to lower blood pressure